Prognostic and predictive implications of the intrinsic subtypes and gene expression signatures in early-stage HER2+ breast cancer: a pooled analysis of CALGB 40601 (Alliance), NeoALTTO and NSABP B-41 trials
- Citation:
- J Clin Oncol vol 40 (16_suppl) 509-509
- Meeting Instance:
- ASCO 2022
- Year:
- 2022
- Type:
- Abstract
- Sub type:
- Poster Discussion
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- 4006
- Pharmas:
- GSK/Novartis
- Grants:
- U10CA180821, U24CA196171, P50-CA58823, R01-CA229409, P30CA051008
- Corr. Author:
- Authors:
- Aranzazu Fernandez-Martinez Mattia Rediti Gong Tang Tomás Pascual Katherine A. Hoadley David Venet Naim U. Rashid Patricia A. Spears Md N. Islam David Goerlitz Rong Hu Peter Lucas Sandra M. Swain Christos Sotiriou Charles M. Perou Lisa A. Carey
- Networks:
- CAPITAL, LAPS-NC007, ME040
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-40601, NeoALTTO, NSABP B-41
- Phases:
- 3
- Keywords: